Diaceutics PLC (AIM:DXRX)

Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.1	7.34	12.74	16.67	19.84	19.68
Cash & Short-Term Investments	8.1	7.34	12.74	16.67	19.84	19.68
Cash Growth	-21.98%	-42.37%	-23.54%	-16.00%	0.84%	-22.10%
Accounts Receivable	18.04	19.71	14.81	9.83	8.37	7
Other Receivables	0.65	1.14	0.89	0.3	2.05	2.92
Receivables	18.69	20.85	15.7	10.13	10.43	9.92
Prepaid Expenses	2.61	1.05	1.08	1.24	0.63	0.43
Other Current Assets	-	0.12	-	-	-	0.04
Total Current Assets	29.41	29.36	29.53	28.04	30.9	30.06
Property, Plant & Equipment	2.52	1.66	1.68	1.9	2.09	2.13
Other Intangible Assets	15.75	16.08	15.41	15.26	15.04	12.61
Long-Term Deferred Tax Assets	4.48	2.9	2	1.14	0.05	0
Long-Term Deferred Charges	-	-	-	-	0.18	0.22
Total Assets	52.15	50.01	48.62	46.34	48.26	45.01

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.14	1.54	1.22	1.07	0.76	0.51
Accrued Expenses	4.4	6.23	5.51	2.26	2	1.31
Short-Term Debt	-	-	-	-	-	0.13
Current Portion of Leases	0.28	0.27	0.15	0.15	0.12	0.15
Current Income Taxes Payable	0.62	0.03	0	0.47	0.42	0.33
Current Unearned Revenue	1.66	0.4	0.34	0.41	0.41	0.21
Other Current Liabilities	0.42	0.09	0.54	0.04	0.04	-
Total Current Liabilities	11.51	8.55	7.77	4.38	3.75	2.63
Long-Term Leases	1.82	0.88	0.91	1.06	1.21	1.29
Long-Term Deferred Tax Liabilities	-	-	-	0.03	0.71	0.45
Other Long-Term Liabilities	0.07	0.1	0.09	0.09	0.08	-
Total Liabilities	13.4	9.53	8.76	5.56	5.74	4.36

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.17	0.17	0.17	0.17	0.17	0.17
Additional Paid-In Capital	-	-	-	37.13	37.13	36.86
Retained Earnings	39.74	41.6	40.63	4.04	5.34	4.08
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.26	-0.17
Comprehensive Income & Other	-0.84	-0.98	-0.63	-0.24	0.14	-0.3
Shareholders' Equity	38.75	40.48	39.86	40.79	42.51	40.65
Total Liabilities & Equity	52.15	50.01	48.62	46.34	48.26	45.01

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.09	1.15	1.06	1.21	1.33	1.56
Net Cash (Debt)	6.01	6.19	11.68	15.46	18.51	18.11
Net Cash Growth	-35.05%	-47.00%	-24.43%	-16.48%	2.20%	-27.94%
Net Cash Per Share	0.07	0.07	0.14	0.18	0.22	0.21
Filing Date Shares Outstanding	84.74	84.66	84.52	84.25	84.26	83.94
Total Common Shares Outstanding	84.74	84.66	84.52	84.25	84.26	83.94
Working Capital	17.89	20.81	21.76	23.66	27.14	27.43
Book Value Per Share	0.46	0.48	0.47	0.48	0.50	0.48
Tangible Book Value	23	24.4	24.44	25.52	27.47	28.04
Tangible Book Value Per Share	0.27	0.29	0.29	0.30	0.33	0.33
Machinery	0.92	0.9	0.83	0.73	0.62	0.48
Leasehold Improvements	0.53	0.53	0.53	0.53	0.53	0.48
Order Backlog	-	38.92	24.93	26.52	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 26, 2026

Data Sources Report a data error